Table 2 Results obtained for the described UPLC-MS/MS & HPLC-UV methods for determination of OG in bulk and tablets.
From: Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Item | UPLC-MS/MS | HPLC-UV |
|---|---|---|
Regression Eq. | Y = 14.561 × +310.35 | Y = 1070.3 × +30.4 |
Correlation Co. | 0.9999 | 0.9997 |
*LOD | 6.67 ng/mL | 0.67 µg/mL |
*LOQ | 20 ng/mL | 2 µg/mL |
Range | 20–2700 ng/mL | 2–10 µg/mL |
Accuracy (*R%) | 99.88% ± 0.7 | — |
Precision (*% RSD) | 0.71% | — |
Tablets (Marizev®) | Recovery = 98.08% | — |